Filter
1420
Filtered Results: 1420
Text search:
microscopy
Featured
Recommendations
156
New Publications
420
Language
Document type
No document type
948
Guidelines
196
Studies & Reports
138
Manuals
61
Strategic & Response Plan
27
Training Material
17
Fact sheets
16
Situation Updates
12
Infographics
2
Brochures
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
111
Western and Central Europe
46
Kenya
42
South Africa
37
Nepal
31
Ethiopia
30
Tanzania
29
Eastern Europe
29
Rwanda
28
Nigeria
27
Malawi
26
Uganda
23
Latin America and the Carribbean
23
Africa
23
Global
23
Ghana
22
Liberia
21
Bangladesh
18
Zambia
17
Sierra Leone
16
Congo, Democratic Republic of
16
Senegal
14
Paraguay
14
Cambodia
13
Philippines
12
Mozambique
12
Colombia
12
South–East Asia Region
12
Namibia
11
Myanmar / Burma
11
Zimbabwe
10
Argentina
10
Peru
10
Brazil
9
Botswana
9
West and Central Africa
9
Benin
8
East and Southern Africa
8
Burkina Faso
7
Cameroon
7
Ukraine
7
Bolivia
7
Haiti
6
Ecuador
6
Middle East and North Africa
6
Angola
5
Germany
4
Lesotho
4
Asia
4
Russia
4
Niger
3
Syria
3
Indonesia
3
El Salvador
3
Western Pacific Region
3
Venezuela
3
Albania
3
Tajikistan
3
Georgia
3
Mali
2
Pakistan
2
South Sudan
2
Lebanon
2
China
2
Papua New Guinea
2
Central African Republic
2
Eswatini/ Swaziland
2
Madagascar
2
Eastern Europe and Central Asia
2
Armenia
2
Timor Leste/ East Timor
2
Moldova
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Togo
1
Somalia
1
Iraq
1
Jordan
1
Afghanistan
1
Turkey
1
Chad
1
Gambia
1
Sudan
1
North Macedonia
1
Greece
1
Sri Lanka
1
Chile
1
Fiji
1
Bhutan
1
Southern Africa
1
Congo-Brazzaville
1
Iran
1
Kazakhstan
1
Vietnam
1
Uruguay
1
Jamaica
1
Tunisia
1
Spain
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
659
Clinical Guidelines
215
Pharmacy & Technologies
66
Public Health
61
Women & Child Health
38
Key Resources
17
Capacity Building
15
Toolboxes
TB
395
NTDs
97
HIV
64
Rapid Response
37
COVID-19
35
Pharmacy
23
AMR
21
Caregiver
18
Ebola
15
Polio
14
Mental Health
11
NCDs
11
Refugee
10
Planetary Health
10
Conflict
7
Natural Hazards
6
Zika
5
Disability
4
Cholera
3
Global Health Education
3
Health Financing Toolbox
2
Specific Hazards
1
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
